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Abstract Preprodermaseptins are a group of antimicrobial
peptide precursors found in the skin of a variety of frog species.
Precursors of this family have very similar N-terminal pre-
prosequences followed by markedly different C-terminal domains
that correspond to mature antimicrobial peptides. Some of these
peptides are 24^34 amino acids long and form well-behaved
amphipathic K-helices, others are disulfide-linked peptides of 20^
46 residues, still others, highly hydrophobic, are the smallest
antimicrobial peptides known so far being only 10^13 residues in
length. All these peptides are broad-spectrum microbicides that
kill many bacteria, protozoa, yeasts and fungi by destroying or
permeating the microbial membrane. In frogs belonging to the
genus Phyllomedusinae, preprodermaseptins encoded peptides
also include dermorphins and deltorphins, D-amino acid-contain-
ing heptapeptides which are very potent and specific agonists of
the W- or N-opioid receptors. The remarkable similarity between
preproregions of precursors that give rise to peptides with very
different primary structures, conformations and activities
suggests that the corresponding genes originate from a common
ancestor. The high conservation of the precursor prepropart
indicates that this region must have an important function.
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1. Introduction
The production of gene-encoded antimicrobial peptides as
an immune strategy is widely used in nature and has been
conserved in evolution. Small-sized antimicrobial peptides,
named bacteriocins, have been produced by a number of
Gram-positive and Gram-negative bacteria for million of
years for containing the proliferation of microorganisms
that are closely related or con¢ned within the same ecological
niche, thus helping the producing microbe to compete for
limited resources [1^6]. In vertebrates, cationic antimicrobial
peptides, 10^46 residues long, are secreted by specialized epi-
thelial cells to form a ¢rst line of host defense against noxious
microorganisms and to control bacterial proliferation in the
respiratory tract, the gastrointestinal and genital systems and
the skin [7^9]. Whereas many antibiotics, or secondary metab-
olites, disable microorganisms over a period of days by inhib-
iting critical enzymes, most of the antimicrobial peptides iso-
lated from vertebrates kill microorganisms rapidly by
destroying or permeating the microbial membrane and im-
pairing ability to carry out anabolic processes [7^9]. This
makes them promising candidates for inclusion in new treat-
ments of nosocomial infections and multi-drug-resistant infec-
tions [10].
Since the discovery in 1969 of bombinin in the skin of the
frog Bombina [11], the ¢rst gene-encoded peptide antibiotic
originating from the mucosal epithelium of a vertebrate ani-
mal amphibian skin has become an important source of new
antimicrobial agents [7^9]. Frog skin secretions are a rich
source of biologically active peptides which are very similar
to mammalian peptides which interact with receptors of the
central and peripheral nervous system and the gastrointestinal
tract [12^14]. There are many examples, including tyrotropin-
releasing hormone, angiotensins, caeruleins/cholecystokinins,
tachykinins, bradykinins and bombesin/gastrin-releasing pep-
tide [14], as well as pancreatic polypeptide/peptide tyrosine-
tyrosine/neuropeptide tyrosine [15] and calcitonin gene-related
peptide [16]. The frog dermatous glands also produce huge
amounts of cytolytic and antimicrobial peptides that defend
the naked skin against the microbe-laden external environ-
ment and assist in wound repair. As a rule, a given amphibian
species produces a unique repertoire of small-sized peptide
antibiotics that have overlapping structural features, but often
target speci¢c microorganisms. It is thought that the simulta-
neous presence of closely related antimicrobial molecules act-
ing in synergy provides frogs with a better shield against a
wider range of harmful invaders, bacterial, fungal and proto-
zoan.
Amphibians belonging to di¡erent families, genera and spe-
cies store distinct set(s) of antimicrobial peptides with a di¡er-
ing chain length, charge, hydrophobicity and spectrum of ac-
tion. These peptides are often produced in such enormous
quantities that it is possible to isolate enough material from
a single animal to determine its amino acid sequence and
establish its antimicrobial spectrum.
The microbicidal skin peptides of the anura frogs are
grouped into three broad families on the basis of their se-
quence/tri-dimensionnal structure characteristics [7^9] : (a) lin-
ear amphipathic helix forming peptides such as the magainins
and related peptides from the mesobatrachia African clawed
frog Xenopus laevis, the bombinins from the archeobatrachia
Bombina sp. and the dermaseptins from the neobatrachia
South American arboreal frogs Phyllomedusa. These peptides
manifest broad-spectrum antimicrobial activity against bacte-
ria, yeast, protozoa and fungi but have no or little harmful
e¡ect on human cells. (b) Four di¡erent groups of related
peptides isolated from various species of the Ranidae family
(neobatrachia), namely the brevinins-1, -2 and the esculentins-
1 and -2. Di¡erent from the peptides mentioned above, they
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all contain two cysteine residues at the C-terminus which are
linked in a disul¢de bridge. (c) The temporins, isolated from
Rana temporari, are the smallest antimicrobial peptides known
so far being only 10^13 residues in length.
2. The preprodermaseptins, a novel family of antimicrobial
peptide precursors
A rapidly expanding group of antimicrobial peptide precur-
sors with unique features has recently been identi¢ed in frog
skin [17^24]. Precursors belonging to this family, tentatively
designated preprodermaseptins, show an N-terminal preprose-
quence of approximately 50 residues which is highly conserved
both intra- and inter-species (82% intraspecies amino acid
identity in P. bicolor ) and markedly diverse C-terminal se-
quences corresponding to antimicrobial peptides (Fig. 1). The
conserved preproregion includes a 22 residue signal peptide
and a 16^25 residue acidic propiece which is terminated by
a typical prohormone processing signal Lys-Arg. Also, the 5P-
untranslated regions in the corresponding mRNAs are V50%
identical at least over the ¢rst 20 bp immediately upstream of
the ATG initiation codon, but sequences diverged beyond that
point. The similarity is not quite as high in the 3P-untranslated
region of the mRNAs. The presence of a conserved 5P-region
in the mRNAs of this group of precursors allowed for the
ampli¢cation of the cDNA of novel putative congeners in
which the conserved preproregion is followed by peptide pro-
genitor sequences with structural features consistent with anti-
microbial activity [25].
At present, 47 chemically di¡erent antimicrobial peptides
corresponding to the C-terminal variable sequences of precur-
sors belonging to the preprodermaseptin family have been
fully characterized in six di¡erent frog species (Table 1). The
mature antimicrobial peptides have all been given individual
names and grouped to form seven distinct peptide subfamilies
on the basis of their origins and/or structural characteristics.
They include the dermaseptins B [19,26,27] and phylloxin [28],
linear K-helical peptides from Phyllomedusa ssp., brevinins
and esculentins, disul¢de-bridged peptides from Rana ssp.
[20^23,29^31], and the temporins, 10^13 residues long pep-
tides from R. temporaria [24]. Studies on the biosynthesis
and intracellular processing of dermaseptins B from P. bicolor
indicate that they are synthesized in the multi-nucleated cells
of the granular glands of the skin as prepropeptides which are
processed by the removal of the signal peptide to the proform
and then stored in the large granules of the glands. Glands
may release their content onto the skin surface by a holocrine
mechanism involving rupture of the plasma membrane and
extrusion of the granules through a duct opening to the sur-
face.
The remarkable similarity between preproregions of precur-
sors that encode structurally diverse end products in distantly
related frog species suggests that the corresponding genes
originate from a common ancestor. Genes encoding derma-
septins B from P. bicolor have been cloned. They show a two
exon coding structure, the ¢rst containing codons for the con-
served 22 residue signal peptide and the ¢rst three glutamic
residues of the acidic propiece and the second exon coding the
remainder of the conserved acidic propiece plus the processing
signal Lys-Arg and a dermaseptin B progenitor sequence
[32,33]. The small intron that interrupts the two coding exons
exhibits strong sequence conservation in all the dermaseptin
genes, suggesting that gene family expansion may have oc-
curred recently or that speci¢c gene conversion events have
occurred to ensure overall sequence conservation. Since the
conserved preproregion is in the same gene as the mature
peptide, it cannot have been added on by post-transcriptional
events.
3. Structure and activity of the antimicrobial peptides
Although di¡ering widely in length and amino acid se-
Fig. 1. (A) Schematic representation of precursors of the preprodermaseptin family. (B) Alignment of the amino acid sequences of the preprore-
gions of representative members of the preprodermaseptins B, preprobrevinins-1 and -2, preproesculentins-1 and preprotemporins, including the
signal peptide (residues 1^22), the acidic propiece and the processing site Lys-Arg. Identical (black background) and similar (shaded back-
ground) residues are highlighted. Gaps (-) have been introduced to maximize sequence similarities. The arrow indicates the putative cleavage
site of the signal peptide.
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quence (Table 1), all these peptides are polycationic, amphi-
pathic and membranotropic. Dermaseptins B and phylloxin
form a well-behaved K-helix in an anisotropic environment,
such as a membrane interface, containing sharply demarcated
polar and non-polar surfaces. These peptides are cidal against
a very broad spectrum of microorganisms, including bacteria,
fungi, protozoa and yeast, but di¡er widely in their potency
for killing the various agents [19,28,33]. It is noteworthy that
the antimicrobial potencies are essentially independent of the
bacterial envelope structure. The toxicity of dermaseptins B is
a direct consequence of their ability to collapse the electro-
chemical transmembrane potential of the target cells [33].
Although the precise mechanism by which dermaseptins B
act and the molecular basis for their selective cytotoxicity
are poorly understood, evidence suggests that these peptides
permeate the target cells via a no-pore carpet-like mechanism
or the formation of a transmembrane bundle of helices [34^
38].
The brevinins and the esculentins are characterized by the
presence of two cysteine residues in positions one and seven
counted from the C-terminus, which are linked in a disul¢de
bridge. The structure of some of these peptides has been an-
alyzed by CD spectroscopy, NMR spectroscopy and molec-
ular modeling [39^42]. Type-1 brevinins have a poorly struc-
tured hydrophobic N-terminal region, a proline hinge region
in the middle and a C-terminal amphipathic loop delineated
Table 1
Antimicrobial peptides of the preprodermaseptin family
Dermaseptin B
Dermaseptin B1 AMWKDVLKKIGTVALHöööAGKAALGAVADTISQa [27]
Dermaseptin B2 GLWSKI-KEVGKEAAKAAAKAAGKAALGAVSEAV^a [26,27]
Dermaseptin B3 ALWKNMLKGIGKööööööLAGQAALGAVKTLVGA [19]
Dermaseptin B4 ALWKDILKNVGKööööööAAGKAVLNTVTDMVNQa [19]
Dermaseptin B5 GLWNKI-KEAAKööööööSAGKAALGFVNEMV^a [19]
Dermaseptin B6 ALWKDILKNööööööööööAGKAALNEINQLVNQa [19]
Phylloxin
Phylloxin GWMSKIASGIGTFLSGIGQQa [28]
Brevinin-1
Brevinin-1 FLPVLAGIAAKVVPALFCKITKKC [29]
Brevinin-1E FLPLLAGLAANFLPKIFCKITRKC [20,30]
Brevinin-1EA FLPAIFRMAAKVVPTIICSITKKC [20,30]
Brevinin-1EB VIPFVASVAAEMMQHVYCAASRKC [20,30]
Brevinin-1EC FLPLLAGLAANFFPKIFCKITRKC [20,30]
Ranalexin FFGGLIKIVPAMIPKIFCKITRKC [21]
Gaegurin-5 FLGALFKVASKVLPSVFCAITKKC [23]
Gaegurin-6 FLPLLAGLAANFLPTIICKISYKC [23]
Brevinin-2
Brevinin-2 G-LLDSLKGFAATAGKGVLQSLLSTASCKLAKTC [29]
Brevinin-2E G-IMDTLKNLAKTAGKGALQSLLNKASCKLSGQC [20,30]
Brevinin-2EA G-ILDTLKLNAISAAKGAAQGLVNKASCKLSGQC [20,30]
Brevinin-2EB G-ILDTLKNLAKTAGKGALQGLVKMASCKLSGQC [20,30]
Brevinin-2EC GILLDKLKNFAKTAGKGVLQSLLNTASCKLSGQC [20,30]
Brevinin-2ED G-ILDSLKNLAKNAGööQILLNKASCKLSGQC [20,30]
Brevinin-2EE G-IFDKLKNFAKööGVAQSLLNKASCKLSGQC [20,30]
Brevinin-2EF G-IMDTLKNLAKTAGKGALQSLVKMASCKLSGQC [20,30]
Gaegurin-1 S-LFSLIKAGAKFLGKNLLKQGACYAACKASKQC [23]
Gaegurin-2 G-IMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC [23]
Gaegurin-3 G-IMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC [23]
Rugosin A G-LLNTFKDWAISIAKGAGKGVLTTLSCKLDKSC [31]
Rugosin B S-LFSLIKAGAKFLGKNLLKQGAQYAACKVSKEC [31]
Esculentin-1
Esculentin-1 GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC [30]
Esculentin-1A GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC [20]
Esculentin-1B GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC [20]
Esculentin-2
Esculentin-2A GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC [20]
Esculentin-2B GIFSLVKGAAKLAGKGLAKEGGKFGLELIACKIAKQC [20]
Gaegurin-4 GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC [23]
Rugosin C GILDSFKQFAKGVGKDLIKGAAQGVLSTMSCKLAKTC [31]
Temporin
Temporin A FLPLIGRVLSGILa [24]
Temporin B LLPIVGNLLKSLLa [24]
Temporin C LLPILGNLLNGLLa [24]
Temporin D LLPIVGNLLNSLLa [24]
Temporin E VLPIIGNLLNSLLa [24]
Temporin F FLPLIGKVLSGILa [24]
Temporin G FFPVIGRILNGILa [24]
Temporin H LSPNLLKSLLa [24]
Temporin K LLPNLLKSLLa [24]
Temporin L FVQWFSKFLGRILa [24]
Peptides are grouped to form seven subfamilies (bold letters) on the basis of their structural characteristics. Gaps (^) have been introduced to
maximize sequences similarity.
aAmidated C-terminus.
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by the disul¢de bridge. The disul¢de bridge might stabilize the
induction of a helical structure spanning residues 8^17 in a
lipid membrane environment. Esculentins and brevinins have
a distinct activity spectrum whereas peptides within each sub-
family do not show signi¢cant di¡erences in their cell lytic
activities. Most of these peptides also exhibit hemolytic activ-
ity. Temporins have a length of 10^13 residues and a limited
antimicrobial spectrum [24]. Although temporins show se-
quence similarity to hemolytic peptides isolated from Vespa
venom [43], they do not lyse erythrocytes.
4. Preprodermaseptin-encoded peptides also include opioids
The conserved preproregion of the dermaseptin precursors
has striking similarities to plurifunctional precursor proteins
preprodermorphin [44] and preprodeltorphins [45]. Dermor-
phin, Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 [46], deltorphin
A, Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2 [47^49], and the
deltorphins B and C, Tyr-D-Ala-Phe-Xaa-Val-Val-Gly-NH2
(where Xaa is either Asp or Glu) [50], are opioid heptapeptide
amides isolated from Phyllomedusa ssp. skin which have been
shown to be highly potent at and exquisitely selective for the
W- and N-opioid receptors, respectively [51,52]. These peptides
are synthesized as a part of two larger precursor proteins
containing multiple copies of the heptapeptide bioactive
sequences (Fig. 2). Precursors of this family are composed
of a signal peptide of 22 residues, followed by an acidic
propiece of 25^26 residues which terminates with two consec-
utive basic amino acids Lys-Arg and an opioid peptide pro-
genitor sequence. Whereas preprodermaseptins contain a sin-
gle copy of the acidic propiece and an antimicrobial peptide
assembled in tandem, preprodermorphin and preprodeltor-
phins are made of ¢ve highly homologous repeats of this
tandem module. A comparison of the cDNA and deduced
amino acid sequences of the dermaseptin and opioid precur-
sors revealed that the signal peptides (72% identical at the
amino acid level) and the acidic propeptides (V50% identical
at the amino acid level) are highly similar. This similarity also
extends into the 5P-untranslated regions of the respective
mRNAs.
Dermorphin and the deltorphins are thus unexpected addi-
tions to the structurally and functionally diverse peptide sub-
families associated with the rapidly evolving C-terminal do-
mains of the dermaseptin family of precursors.
Fig. 2. (A) Block diagrams of preprodermaseptin B2 cDNA, preprodermorphin (clone D-1/2) [44] and preprodeltorphin (clone AD 2) [45]
cDNAs. Regions of great similarity among all three cDNAs are labelled with the same boxed patterns as follows: 5P NC, 5P-non-coding region
(dark dotted box); signal peptide (hatched box); acidic spacer peptide (black box); C, cysteine; KR, Lys-Arg dipeptide; GEQ/A, Gly-Glu-Gln/
Ala tripeptide. Open boxes denote sequences with low or no homology among the four precursors: 3P NC, 3P-non-coding region; DRM, der-
morphin; DREK, dermenkephalin; DRM-RP, dermorphin-related peptide Tyr-Ala-Phe-Trp-Tyr-Pro-Asn; DELT 1, deltorphin I. Only partial
sequences of he cDNAs encoding preprodermorphin and preprodeltorphins are shown since the number of repeats varies and is clone-depend-
ent. In D-1/2, the unit corresponding to DRM-GEA-acidic spacer-KR is repeated four times. In AD 2, the unit corresponding to DELT-GEA-
acidic spacer-KR is repeated three times. (B) Maximized multiple sequence alignments of the amino acid sequences of the preproregions of pre-
prodermaseptin B2, preprodermorphin and preprodeltorphins, including the signal peptide (residues 1^22), the acidic propiece and the process-
ing site Lys-Arg. Identical (black background) and similar (shaded background) residues are highlighted. Gaps (^) have been introduced to
maximize sequence similarities.
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5. Conclusion
The preprodermaseptin family counts numerous members
which are strikingly diverse in length, primary structure, con-
formation, biological activity and mode of action. Several
mechanisms may contribute to the generation of precursors
containing conserved preproregions associated with multiple
forms of mature active peptides. If the dermaseptin B genes
are representative of other preprodermaseptin-like genes, this
organization would favor recombination mechanisms, or exon
shu¥ing, involving association of diverse coding exons 2 with
the ¢rst highly conserved coding exon. The duplication and
recombinational events that promoted the association of such
a homologous exon with sequences encoding a variety of end
products in various amphibian species remain to be elucidated
but are likely to have occurred at the very early stages of
evolution.
Although the overall organization of eukaryotic signal pep-
tides is evolutionarily conserved, no sequence similarity exists
[53]. The evolutionary pressure which results in the conserva-
tion of the signal peptide in preprodermaseptins suggests that
this topogenic sequence may also help to ensure the correct
proteolytic maturation of the precursor or targeting the ma-
ture peptide to the secretory granules.
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